Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
20,707
archived clinical trials in
Gastrointestinal

A Pilot Study of the Effect of Dietary Fat Type and Amount on Vitamin D3 Absorption
A Pilot Study of the Effect of Dietary Fat Type and Amount on Vitamin D3 Absorption
Status: Enrolling
Updated:  5/15/2012
Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University
mi
from
Boston, MA
A Pilot Study of the Effect of Dietary Fat Type and Amount on Vitamin D3 Absorption
A Pilot Study of the Effect of Dietary Fat Type and Amount on Vitamin D3 Absorption
Status: Enrolling
Updated: 5/15/2012
Jean Mayer USDA Human Nutrition Research Center on Aging at Tufts University
mi
from
Boston, MA
Click here to add this to my saved trials
Vitamin D3 Supplementation Pilot Study
Pilot Study of Vitamin D3 Supplementation and Outcomes in Vitamin D Deficient Obese, African American Adolescents
Status: Enrolling
Updated:  5/15/2012
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Vitamin D3 Supplementation Pilot Study
Pilot Study of Vitamin D3 Supplementation and Outcomes in Vitamin D Deficient Obese, African American Adolescents
Status: Enrolling
Updated: 5/15/2012
Children's Hospital of Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Pilot Study of Varenicline to Treat Opioid Dependence
The Role of Varenicline in Treating Opioid Dependence: A Pilot Study
Status: Enrolling
Updated:  5/16/2012
Mayo Clinic Rochester
mi
from
Rochester, MN
Pilot Study of Varenicline to Treat Opioid Dependence
The Role of Varenicline in Treating Opioid Dependence: A Pilot Study
Status: Enrolling
Updated: 5/16/2012
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
A Placebo-Controlled Study of Clonidine for Fecal Incontinence.
A Placebo-Controlled Study of Clonidine for Fecal Incontinence.
Status: Enrolling
Updated:  5/23/2012
Mayo Clinic Rochester
mi
from
Rochester, MN
A Placebo-Controlled Study of Clonidine for Fecal Incontinence.
A Placebo-Controlled Study of Clonidine for Fecal Incontinence.
Status: Enrolling
Updated: 5/23/2012
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Indigo Carmine Staining and Narrow Band Imaging (NBI) of Colonic Mucosa for Detection of Dysplasia in Ulcerative Colitis
A Pilot Study for the Determination of Inter-observer Variation for Abnormalities Detected by Indigo Carmine Staining and Narrow Band Imaging Among Patients Undergoing Surveillance Colonoscopy for Ulcerative Colitis
Status: Enrolling
Updated:  5/23/2012
Mayo Clinic Florida
mi
from
Jacksonville, FL
Indigo Carmine Staining and Narrow Band Imaging (NBI) of Colonic Mucosa for Detection of Dysplasia in Ulcerative Colitis
A Pilot Study for the Determination of Inter-observer Variation for Abnormalities Detected by Indigo Carmine Staining and Narrow Band Imaging Among Patients Undergoing Surveillance Colonoscopy for Ulcerative Colitis
Status: Enrolling
Updated: 5/23/2012
Mayo Clinic Florida
mi
from
Jacksonville, FL
Click here to add this to my saved trials
A Comparison of the Treatment of Pressure Ulcers in Spinal Cord Injury Subjects With HP011—101 Ointment to That of Treatment With the Sites Usual Standard Care
Comparison of HP011-101 to Standard Care in the Management of Stage I-II Pressure Ulcers in Subjects With Spinal Cord Injury
Status: Enrolling
Updated:  5/24/2012
VA Medical Center, Long Beach
mi
from
Long Beach, CA
A Comparison of the Treatment of Pressure Ulcers in Spinal Cord Injury Subjects With HP011—101 Ointment to That of Treatment With the Sites Usual Standard Care
Comparison of HP011-101 to Standard Care in the Management of Stage I-II Pressure Ulcers in Subjects With Spinal Cord Injury
Status: Enrolling
Updated: 5/24/2012
VA Medical Center, Long Beach
mi
from
Long Beach, CA
Click here to add this to my saved trials
A Comparison of the Treatment of Pressure Ulcers in Spinal Cord Injury Subjects With HP011—101 Ointment to That of Treatment With the Sites Usual Standard Care
Comparison of HP011-101 to Standard Care in the Management of Stage I-II Pressure Ulcers in Subjects With Spinal Cord Injury
Status: Enrolling
Updated:  5/24/2012
Santa Clara Valley Medical Center
mi
from
San Jose, CA
A Comparison of the Treatment of Pressure Ulcers in Spinal Cord Injury Subjects With HP011—101 Ointment to That of Treatment With the Sites Usual Standard Care
Comparison of HP011-101 to Standard Care in the Management of Stage I-II Pressure Ulcers in Subjects With Spinal Cord Injury
Status: Enrolling
Updated: 5/24/2012
Santa Clara Valley Medical Center
mi
from
San Jose, CA
Click here to add this to my saved trials
A Comparison of the Treatment of Pressure Ulcers in Spinal Cord Injury Subjects With HP011—101 Ointment to That of Treatment With the Sites Usual Standard Care
Comparison of HP011-101 to Standard Care in the Management of Stage I-II Pressure Ulcers in Subjects With Spinal Cord Injury
Status: Enrolling
Updated:  5/24/2012
James A. Haley Veterans Hospital, Tampa
mi
from
Tampa, FL
A Comparison of the Treatment of Pressure Ulcers in Spinal Cord Injury Subjects With HP011—101 Ointment to That of Treatment With the Sites Usual Standard Care
Comparison of HP011-101 to Standard Care in the Management of Stage I-II Pressure Ulcers in Subjects With Spinal Cord Injury
Status: Enrolling
Updated: 5/24/2012
James A. Haley Veterans Hospital, Tampa
mi
from
Tampa, FL
Click here to add this to my saved trials
A Comparison of the Treatment of Pressure Ulcers in Spinal Cord Injury Subjects With HP011—101 Ointment to That of Treatment With the Sites Usual Standard Care
Comparison of HP011-101 to Standard Care in the Management of Stage I-II Pressure Ulcers in Subjects With Spinal Cord Injury
Status: Enrolling
Updated:  5/24/2012
Kessler Institute for Rehabilitation
mi
from
West Orange, NJ
A Comparison of the Treatment of Pressure Ulcers in Spinal Cord Injury Subjects With HP011—101 Ointment to That of Treatment With the Sites Usual Standard Care
Comparison of HP011-101 to Standard Care in the Management of Stage I-II Pressure Ulcers in Subjects With Spinal Cord Injury
Status: Enrolling
Updated: 5/24/2012
Kessler Institute for Rehabilitation
mi
from
West Orange, NJ
Click here to add this to my saved trials
A Comparison of the Treatment of Pressure Ulcers in Spinal Cord Injury Subjects With HP011—101 Ointment to That of Treatment With the Sites Usual Standard Care
Comparison of HP011-101 to Standard Care in the Management of Stage I-II Pressure Ulcers in Subjects With Spinal Cord Injury
Status: Enrolling
Updated:  5/24/2012
Carolinas Research
mi
from
Charlotte, NC
A Comparison of the Treatment of Pressure Ulcers in Spinal Cord Injury Subjects With HP011—101 Ointment to That of Treatment With the Sites Usual Standard Care
Comparison of HP011-101 to Standard Care in the Management of Stage I-II Pressure Ulcers in Subjects With Spinal Cord Injury
Status: Enrolling
Updated: 5/24/2012
Carolinas Research
mi
from
Charlotte, NC
Click here to add this to my saved trials
RESPOND Restoring Equilibrium and Wound Stimulation to Promote Healing Of Non-healing DFUs
Status: Enrolling
Updated:  5/30/2012
Georgetown University Hospital
mi
from
Washington,
RESPOND Restoring Equilibrium and Wound Stimulation to Promote Healing Of Non-healing DFUs
Status: Enrolling
Updated: 5/30/2012
Georgetown University Hospital
mi
from
Washington,
Click here to add this to my saved trials
Evaluate the Change in Iron, Vitamin D, and C-Reactive Protein Level (CRP) in a 12 to 24 Week Period
Observational Study to Evaluate Changes in Iron, Vit-D, and CRP During a Twelve to Twenty-Four Week Supervised Triathlon Training Program
Status: Enrolling
Updated:  5/31/2012
Avera Sports Institute
mi
from
Sioux Falls, SD
Evaluate the Change in Iron, Vitamin D, and C-Reactive Protein Level (CRP) in a 12 to 24 Week Period
Observational Study to Evaluate Changes in Iron, Vit-D, and CRP During a Twelve to Twenty-Four Week Supervised Triathlon Training Program
Status: Enrolling
Updated: 5/31/2012
Avera Sports Institute
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Treatment Study: Reducing Cocaine/Heroin Abuse With SR-Amphetamine and Buprenorphine (ARC)
Reducing Cocaine/Heroin Abuse With SR-Amphetamine and Buprenorphine (ARC)
Status: Enrolling
Updated:  6/1/2012
Wayne State University
mi
from
Detroit, MI
Treatment Study: Reducing Cocaine/Heroin Abuse With SR-Amphetamine and Buprenorphine (ARC)
Reducing Cocaine/Heroin Abuse With SR-Amphetamine and Buprenorphine (ARC)
Status: Enrolling
Updated: 6/1/2012
Wayne State University
mi
from
Detroit, MI
Click here to add this to my saved trials
Evaluation of SQ109 Plus PPI in Urea Breath Test-Positive Volunteers
Phase 2A Open-label Study to Evaluate Safety, Tolerability, and Antimicrobial Activity of Single, Daily Doses of SQ109 in Urea Breath Test Positive Volunteers
Status: Enrolling
Updated:  6/5/2012
Cesar Salazar, M.D.
mi
from
El Paso, TX
Evaluation of SQ109 Plus PPI in Urea Breath Test-Positive Volunteers
Phase 2A Open-label Study to Evaluate Safety, Tolerability, and Antimicrobial Activity of Single, Daily Doses of SQ109 in Urea Breath Test Positive Volunteers
Status: Enrolling
Updated: 6/5/2012
Cesar Salazar, M.D.
mi
from
El Paso, TX
Click here to add this to my saved trials
Evaluation of SQ109 Plus PPI in Urea Breath Test-Positive Volunteers
Phase 2A Open-label Study to Evaluate Safety, Tolerability, and Antimicrobial Activity of Single, Daily Doses of SQ109 in Urea Breath Test Positive Volunteers
Status: Enrolling
Updated:  6/5/2012
Houston Institute for Clinical Research
mi
from
Houston, TX
Evaluation of SQ109 Plus PPI in Urea Breath Test-Positive Volunteers
Phase 2A Open-label Study to Evaluate Safety, Tolerability, and Antimicrobial Activity of Single, Daily Doses of SQ109 in Urea Breath Test Positive Volunteers
Status: Enrolling
Updated: 6/5/2012
Houston Institute for Clinical Research
mi
from
Houston, TX
Click here to add this to my saved trials
Managing Inflammatory Bowel Disease
Psychosocial Intervention for Children With IBD
Status: Enrolling
Updated:  6/12/2012
Seattle Children's Hospital
mi
from
Seattle, WA
Managing Inflammatory Bowel Disease
Psychosocial Intervention for Children With IBD
Status: Enrolling
Updated: 6/12/2012
Seattle Children's Hospital
mi
from
Seattle, WA
Click here to add this to my saved trials
Cohort Study of Bowel Function Following Robotic-assisted Laparoscopic Sacrocolpopexy
Cohort Study of Bowel Function Following Robotic-assisted Laparoscopic Sacrocolpopexy
Status: Enrolling
Updated:  6/12/2012
Atlantic Health System
mi
from
Morristown, NJ
Cohort Study of Bowel Function Following Robotic-assisted Laparoscopic Sacrocolpopexy
Cohort Study of Bowel Function Following Robotic-assisted Laparoscopic Sacrocolpopexy
Status: Enrolling
Updated: 6/12/2012
Atlantic Health System
mi
from
Morristown, NJ
Click here to add this to my saved trials
Cyclophosphamide in Treating Young Patients With Severe Autoimmune Enteropathy
High-Dose Cyclophosphamide for the Treatment of Severe Autoimmune Enteropathy
Status: Enrolling
Updated:  6/13/2012
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
mi
from
Baltimore, MD
Cyclophosphamide in Treating Young Patients With Severe Autoimmune Enteropathy
High-Dose Cyclophosphamide for the Treatment of Severe Autoimmune Enteropathy
Status: Enrolling
Updated: 6/13/2012
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
mi
from
Baltimore, MD
Click here to add this to my saved trials
Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)
A Phase II Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With NASH
Status: Enrolling
Updated:  6/14/2012
Mochida Investigative Site
mi
from
Dothan, AL
Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)
A Phase II Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With NASH
Status: Enrolling
Updated: 6/14/2012
Mochida Investigative Site
mi
from
Dothan, AL
Click here to add this to my saved trials
Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)
A Phase II Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With NASH
Status: Enrolling
Updated:  6/14/2012
Mochida Investigative Site
mi
from
Tucson, AZ
Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)
A Phase II Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With NASH
Status: Enrolling
Updated: 6/14/2012
Mochida Investigative Site
mi
from
Tucson, AZ
Click here to add this to my saved trials
Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)
A Phase II Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With NASH
Status: Enrolling
Updated:  6/14/2012
Mochida Investigative Site
mi
from
Anaheim, CA
Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)
A Phase II Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With NASH
Status: Enrolling
Updated: 6/14/2012
Mochida Investigative Site
mi
from
Anaheim, CA
Click here to add this to my saved trials
Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)
A Phase II Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With NASH
Status: Enrolling
Updated:  6/14/2012
Mochida Investigative Site
mi
from
Littleton, CO
Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)
A Phase II Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With NASH
Status: Enrolling
Updated: 6/14/2012
Mochida Investigative Site
mi
from
Littleton, CO
Click here to add this to my saved trials
Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)
A Phase II Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With NASH
Status: Enrolling
Updated:  6/14/2012
Mochida Investigative Site
mi
from
Miami, FL
Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)
A Phase II Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With NASH
Status: Enrolling
Updated: 6/14/2012
Mochida Investigative Site
mi
from
Miami, FL
Click here to add this to my saved trials
Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)
A Phase II Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With NASH
Status: Enrolling
Updated:  6/14/2012
Mochida Investigative Site
mi
from
Chicago, IL
Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)
A Phase II Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With NASH
Status: Enrolling
Updated: 6/14/2012
Mochida Investigative Site
mi
from
Chicago, IL
Click here to add this to my saved trials
Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)
A Phase II Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With NASH
Status: Enrolling
Updated:  6/14/2012
Mochida Investigative Site
mi
from
Lexington, KY
Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)
A Phase II Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With NASH
Status: Enrolling
Updated: 6/14/2012
Mochida Investigative Site
mi
from
Lexington, KY
Click here to add this to my saved trials
Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)
A Phase II Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With NASH
Status: Enrolling
Updated:  6/14/2012
Mochida Investigative Site
mi
from
New Orleans, LA
Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)
A Phase II Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With NASH
Status: Enrolling
Updated: 6/14/2012
Mochida Investigative Site
mi
from
New Orleans, LA
Click here to add this to my saved trials
Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)
A Phase II Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With NASH
Status: Enrolling
Updated:  6/14/2012
Mochida Investigative Site
mi
from
Chevy Chase, MD
Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)
A Phase II Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With NASH
Status: Enrolling
Updated: 6/14/2012
Mochida Investigative Site
mi
from
Chevy Chase, MD
Click here to add this to my saved trials
Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)
A Phase II Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With NASH
Status: Enrolling
Updated:  6/14/2012
Mochida Investigative Site
mi
from
Ann Arbor, MI
Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)
A Phase II Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With NASH
Status: Enrolling
Updated: 6/14/2012
Mochida Investigative Site
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)
A Phase II Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With NASH
Status: Enrolling
Updated:  6/14/2012
Mochida Investigative Site
mi
from
Plymouth, MN
Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)
A Phase II Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With NASH
Status: Enrolling
Updated: 6/14/2012
Mochida Investigative Site
mi
from
Plymouth, MN
Click here to add this to my saved trials
Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)
A Phase II Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With NASH
Status: Enrolling
Updated:  6/14/2012
Mochida Investigative Site
mi
from
Jackson, MS
Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)
A Phase II Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With NASH
Status: Enrolling
Updated: 6/14/2012
Mochida Investigative Site
mi
from
Jackson, MS
Click here to add this to my saved trials
Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)
A Phase II Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With NASH
Status: Enrolling
Updated:  6/14/2012
Mochida Investigative Site
mi
from
Plainview, NY
Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)
A Phase II Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With NASH
Status: Enrolling
Updated: 6/14/2012
Mochida Investigative Site
mi
from
Plainview, NY
Click here to add this to my saved trials
Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)
A Phase II Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With NASH
Status: Enrolling
Updated:  6/14/2012
Mochida Investigative Site
mi
from
Durham, NC
Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)
A Phase II Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With NASH
Status: Enrolling
Updated: 6/14/2012
Mochida Investigative Site
mi
from
Durham, NC
Click here to add this to my saved trials
Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)
A Phase II Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With NASH
Status: Enrolling
Updated:  6/14/2012
Mochida Investigative Site
mi
from
Cincinnati, OH
Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)
A Phase II Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With NASH
Status: Enrolling
Updated: 6/14/2012
Mochida Investigative Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)
A Phase II Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With NASH
Status: Enrolling
Updated:  6/14/2012
Mochida Investigative Site
mi
from
Providence, RI
Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)
A Phase II Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With NASH
Status: Enrolling
Updated: 6/14/2012
Mochida Investigative Site
mi
from
Providence, RI
Click here to add this to my saved trials
Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)
A Phase II Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With NASH
Status: Enrolling
Updated:  6/14/2012
Mochida Investigative Site (2 sites)
mi
from
Germantown, TN
Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)
A Phase II Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With NASH
Status: Enrolling
Updated: 6/14/2012
Mochida Investigative Site (2 sites)
mi
from
Germantown, TN
Click here to add this to my saved trials
Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)
A Phase II Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With NASH
Status: Enrolling
Updated:  6/14/2012
Mochida Investigative Site
mi
from
Nashville, TN
Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)
A Phase II Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With NASH
Status: Enrolling
Updated: 6/14/2012
Mochida Investigative Site
mi
from
Nashville, TN
Click here to add this to my saved trials
Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)
A Phase II Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With NASH
Status: Enrolling
Updated:  6/14/2012
Mochida Investigative Site (2 sites)
mi
from
Houston, TX
Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)
A Phase II Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With NASH
Status: Enrolling
Updated: 6/14/2012
Mochida Investigative Site (2 sites)
mi
from
Houston, TX
Click here to add this to my saved trials
Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)
A Phase II Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With NASH
Status: Enrolling
Updated:  6/14/2012
Mochida Investigative Site
mi
from
Houston, TX
Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)
A Phase II Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With NASH
Status: Enrolling
Updated: 6/14/2012
Mochida Investigative Site
mi
from
Houston, TX
Click here to add this to my saved trials
Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)
A Phase II Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With NASH
Status: Enrolling
Updated:  6/14/2012
Mochida Investigative Site
mi
from
Falls Church, VA
Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)
A Phase II Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With NASH
Status: Enrolling
Updated: 6/14/2012
Mochida Investigative Site
mi
from
Falls Church, VA
Click here to add this to my saved trials
Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)
A Phase II Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With NASH
Status: Enrolling
Updated:  6/14/2012
Mochida Investigative Site
mi
from
Seattle, WA
Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH)
A Phase II Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With NASH
Status: Enrolling
Updated: 6/14/2012
Mochida Investigative Site
mi
from
Seattle, WA
Click here to add this to my saved trials
A Clinical Trial of COX and EGFR Inhibition in Familial Polyposis Patients
Genetic Events Leading to APC-Dependent Colon Cancer in High-Risk Families; a Clinical Trial of COX and EGFR Inhibition in Familial Polyposis Patients
Status: Enrolling
Updated:  6/14/2012
Huntsman Cancer Institute at University of Utah
mi
from
Salt Lake City, UT
A Clinical Trial of COX and EGFR Inhibition in Familial Polyposis Patients
Genetic Events Leading to APC-Dependent Colon Cancer in High-Risk Families; a Clinical Trial of COX and EGFR Inhibition in Familial Polyposis Patients
Status: Enrolling
Updated: 6/14/2012
Huntsman Cancer Institute at University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Polycystic Liver Disease in Kidney Transplant
Single Center, Open-label Randomized Prospective Trial: Effect of Sirolimus on Polycystic Liver Disease
Status: Enrolling
Updated:  6/18/2012
Mayo Clinic Rochester
mi
from
Rochester, MN
Polycystic Liver Disease in Kidney Transplant
Single Center, Open-label Randomized Prospective Trial: Effect of Sirolimus on Polycystic Liver Disease
Status: Enrolling
Updated: 6/18/2012
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Feasibility of Transvaginal Cholecystectomy
Feasibility of Transvaginal Cholecystectomy
Status: Enrolling
Updated:  6/20/2012
Mayo Clinic Rochester
mi
from
Rochester, MN
Feasibility of Transvaginal Cholecystectomy
Feasibility of Transvaginal Cholecystectomy
Status: Enrolling
Updated: 6/20/2012
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Combination Therapy With Ursodeoxycholic Acid (UDCA) and All-Trans Retinoic Acid (ATRA) for Treatment of Primary Sclerosing Cholangitis
Combination Therapy With Ursodeoxycholic Acid (UDCA) and All-Trans Retinoic Acid (ATRA) for Treatment of Primary Sclerosing Cholangitis - A Human Pilot Study
Status: Enrolling
Updated:  6/28/2012
Yale University School of Medicine - 333 Cedar St - 1080 LMP
mi
from
New Haven, CT
Combination Therapy With Ursodeoxycholic Acid (UDCA) and All-Trans Retinoic Acid (ATRA) for Treatment of Primary Sclerosing Cholangitis
Combination Therapy With Ursodeoxycholic Acid (UDCA) and All-Trans Retinoic Acid (ATRA) for Treatment of Primary Sclerosing Cholangitis - A Human Pilot Study
Status: Enrolling
Updated: 6/28/2012
Yale University School of Medicine - 333 Cedar St - 1080 LMP
mi
from
New Haven, CT
Click here to add this to my saved trials
Combination Therapy With Ursodeoxycholic Acid (UDCA) and All-Trans Retinoic Acid (ATRA) for Treatment of Primary Sclerosing Cholangitis
Combination Therapy With Ursodeoxycholic Acid (UDCA) and All-Trans Retinoic Acid (ATRA) for Treatment of Primary Sclerosing Cholangitis - A Human Pilot Study
Status: Enrolling
Updated:  6/28/2012
Mayo Clinic Rochester
mi
from
Rochester, MN
Combination Therapy With Ursodeoxycholic Acid (UDCA) and All-Trans Retinoic Acid (ATRA) for Treatment of Primary Sclerosing Cholangitis
Combination Therapy With Ursodeoxycholic Acid (UDCA) and All-Trans Retinoic Acid (ATRA) for Treatment of Primary Sclerosing Cholangitis - A Human Pilot Study
Status: Enrolling
Updated: 6/28/2012
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
The Variability of 25-hydroxyvitamin D Response From Crystalline 25-hydroxyvitamin D3
The Variability of 25-hydroxyvitamin D Response From Crystalline 25-hydroxyvitamin D3 Compared to Native Vitamin D3: A Short Term Pharmacokinetic Study
Status: Enrolling
Updated:  7/3/2012
Creighton University
mi
from
Omaha, NE
The Variability of 25-hydroxyvitamin D Response From Crystalline 25-hydroxyvitamin D3
The Variability of 25-hydroxyvitamin D Response From Crystalline 25-hydroxyvitamin D3 Compared to Native Vitamin D3: A Short Term Pharmacokinetic Study
Status: Enrolling
Updated: 7/3/2012
Creighton University
mi
from
Omaha, NE
Click here to add this to my saved trials
Diagnosis of Intestinal Motility by Image Analysis Using Capsule Endoscopy
Intestinal Motility Evaluation by Endoluminal Image Analysis Using Capsule Endoscopy (CE-EIA): a Multi-center Clinical Trial
Status: Enrolling
Updated:  7/4/2012
Division of Gastroenterology and Hepatology Mayo Clinic
mi
from
Scottsdale, AZ
Diagnosis of Intestinal Motility by Image Analysis Using Capsule Endoscopy
Intestinal Motility Evaluation by Endoluminal Image Analysis Using Capsule Endoscopy (CE-EIA): a Multi-center Clinical Trial
Status: Enrolling
Updated: 7/4/2012
Division of Gastroenterology and Hepatology Mayo Clinic
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Diagnosis of Intestinal Motility by Image Analysis Using Capsule Endoscopy
Intestinal Motility Evaluation by Endoluminal Image Analysis Using Capsule Endoscopy (CE-EIA): a Multi-center Clinical Trial
Status: Enrolling
Updated:  7/4/2012
The Mayo Clinic
mi
from
Rochester, MN
Diagnosis of Intestinal Motility by Image Analysis Using Capsule Endoscopy
Intestinal Motility Evaluation by Endoluminal Image Analysis Using Capsule Endoscopy (CE-EIA): a Multi-center Clinical Trial
Status: Enrolling
Updated: 7/4/2012
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
PII of SBRT & Chemo for Unresectable Cholangiocarcinoma Followed by Liver Transplantation
Phase II Study of Stereotactic Body Radiotherapy (SBRT) and Chemotherapy for Unresectable Cholangiocarcinoma Followed by Liver Transplantation
Status: Enrolling
Updated:  7/9/2012
Stanford University School of Medicine
mi
from
Stanford, CA
PII of SBRT & Chemo for Unresectable Cholangiocarcinoma Followed by Liver Transplantation
Phase II Study of Stereotactic Body Radiotherapy (SBRT) and Chemotherapy for Unresectable Cholangiocarcinoma Followed by Liver Transplantation
Status: Enrolling
Updated: 7/9/2012
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
Chronic Sildenafil for Severe Diaphragmatic Hernia
Chronic Sildenafil for Severe Diaphragmatic Hernia
Status: Enrolling
Updated:  7/16/2012
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Chronic Sildenafil for Severe Diaphragmatic Hernia
Chronic Sildenafil for Severe Diaphragmatic Hernia
Status: Enrolling
Updated: 7/16/2012
Childrens Hospital Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials